Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuroscientific Biopharmaceuticals Ltd. ( (AU:NSB) ) just unveiled an announcement.
Neuroscientific Biopharmaceuticals Ltd announced the issuance of 40,000,000 unquoted equity securities in the form of options exercisable at $0.07, expiring on June 27, 2028. This move is part of a previously announced transaction and reflects the company’s ongoing efforts to secure funding and support its research and development activities, potentially impacting its market position and stakeholder interests.
More about Neuroscientific Biopharmaceuticals Ltd.
Neuroscientific Biopharmaceuticals Ltd is a company operating in the biopharmaceutical industry, focusing on the development of innovative therapies for neurological disorders. The company is engaged in research and development to create treatments that address unmet medical needs in the field of neuroscience.
Average Trading Volume: 428,090
Technical Sentiment Signal: Buy
Current Market Cap: A$13.01M
See more insights into NSB stock on TipRanks’ Stock Analysis page.